Figure 4.

Acceptability Curve for PMO T −3.0/2 Fracture Cohort: Teriparatide vs. Bisphosphonate Treatment.

Murphy et al. BMC Musculoskeletal Disorders 2012 13:213   doi:10.1186/1471-2474-13-213
Download authors' original image